Please try another search
Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People’s Republic of China, the Asia Pacific, Germany, Europe, the Americas, Oceania, and internationally. The company operates through four segments: Proprietary Products, Distribution Products, Technical Services, and Others. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, and ophthalmic disease diagnosis and treatment equipment and related supporting consumables. The Distribution Products segment sells diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment, and related supporting consumables. The Technical Services segment provides warranty services, maintenance services, and after-sales services related consumables. The Others segment provides services related to clinical research organization, and licenses intellectual properties. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology. The company also provides technical services, that includes repair and maintenance services. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Xinwei Liu | 42 | 2018 | Executive Director & CEO |
Li-Shin Wang | 64 | 2022 | Independent Non-Executive Director |
Tieta Gao | 59 | 2017 | Executive Chairman |
David G. Wang | 63 | 2017 | Non-Executive Director |
Xinli Zhao | 57 | 2017 | Executive Director & Chief Compliance Officer |
Fan Shing Chan | 47 | 2022 | Independent Non-Executive Director |
Wenqi Li | 50 | 2021 | CFO & Executive Director |
Jianjun Zhang | 60 | 2017 | Honorary President & Executive Director |
Xin Feng | 54 | 2022 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review